Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Feiteng Huang

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Small (Weinheim an Der Bergstrasse, Germany)|January 20, 2018
Paraptosis-Inducing Nanomedicine Overcomes Cancer Drug Resistance for a Potent Cancer TherapyYongcun Zhou, Feiteng Huang, Ying Yang, et al.
International Journal of Biological Sciences|December 20, 2019
Protein arginine methyltransferase 1 is required for maintenance of normal adult hematopoiesisLei Zhu, Xin He, Haojie Dong, et al.
Aging|July 30, 2020
HDAC4 inhibition disrupts TET2 function in high-risk MDS and AMLFeiteng Huang, Jie Sun, Wei Chen, et al.
Blood Cancer Journal|November 28, 2023
Correction: TET2 deficiency promotes MDS-associated leukemogenesisFeiteng Huang, Jie Sun, Wei Chen, et al.
Molecular Cancer|November 20, 2019
Correction to: KIF5B-RET fusion kinase promotes cell growth by multilevel activation of STAT3 in lung cancerYingying Qian, Shoujie Chai, Zuyu Liang, et al.
Blood Cancer Journal|October 4, 2022
TET2 deficiency promotes MDS-associated leukemogenesisFeiteng Huang, Jie Sun, Wei Chen, et al.
Molecular Cancer|July 23, 2014
KIF5B-RET fusion kinase promotes cell growth by multilevel activation of STAT3 in lung cancerYingYing Qian, Shoujie Chai, Zuyu Liang, et al.
Blood|April 19, 2022
Disruption of dNTP homeostasis by ribonucleotide reductase hyperactivation overcomes AML differentiation blockadeHanying Wang, Xin He, Lei Zhang, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Small (Weinheim an Der Bergstrasse, Germany)|January 20, 2018
Paraptosis-Inducing Nanomedicine Overcomes Cancer Drug Resistance for a Potent Cancer TherapyYongcun Zhou, Feiteng Huang, Ying Yang, et al.
International Journal of Biological Sciences|December 20, 2019
Protein arginine methyltransferase 1 is required for maintenance of normal adult hematopoiesisLei Zhu, Xin He, Haojie Dong, et al.
Aging|July 30, 2020
HDAC4 inhibition disrupts TET2 function in high-risk MDS and AMLFeiteng Huang, Jie Sun, Wei Chen, et al.
Blood Cancer Journal|November 28, 2023
Correction: TET2 deficiency promotes MDS-associated leukemogenesisFeiteng Huang, Jie Sun, Wei Chen, et al.
Molecular Cancer|November 20, 2019
Correction to: KIF5B-RET fusion kinase promotes cell growth by multilevel activation of STAT3 in lung cancerYingying Qian, Shoujie Chai, Zuyu Liang, et al.
Blood Cancer Journal|October 4, 2022
TET2 deficiency promotes MDS-associated leukemogenesisFeiteng Huang, Jie Sun, Wei Chen, et al.
Molecular Cancer|July 23, 2014
KIF5B-RET fusion kinase promotes cell growth by multilevel activation of STAT3 in lung cancerYingYing Qian, Shoujie Chai, Zuyu Liang, et al.
Blood|April 19, 2022
Disruption of dNTP homeostasis by ribonucleotide reductase hyperactivation overcomes AML differentiation blockadeHanying Wang, Xin He, Lei Zhang, et al.
Pageof 1